Drugs / Lisofylline
Lisofylline
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01603121 | Feb 2012 → May 2013 | type 1 diabetes mellitus | Eastern Virginia Medical School | Terminated | No outcome recorded Stop: Enrollment |
| Phase 21 trial | ||||||
| Phase 2 | NCT00464555 | Dec 2006 → Nov 2011 | type 1 diabetes mellitus | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00000579 | Sep 1994 → Jul 2004 | adult acute respiratory distress syndrome | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00896077 Comparator | May → Dec 2009 | type 1 diabetes mellitus | DiaKine Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lisofylline | “A new drug, lisofylline, was selected to replace ketoconazole in the factorial design ventilation protocol.” NCT00000579 ↗ |
| Known as | CT 1501R | ChEMBL registry synonym — accepted as the source's own label CHEMBL1411 ↗ |
| Known as | Lisofilina | ChEMBL registry synonym — accepted as the source's own label CHEMBL1411 ↗ |
| Known as | Lisofylline, (r)- | ChEMBL registry synonym — accepted as the source's own label CHEMBL1411 ↗ |
| Known as | LSF | “Lisofylline (LSF)” NCT00896077 ↗ |
| Known as | Protec | ChEMBL registry synonym — accepted as the source's own label CHEMBL1411 ↗ |
| Modality | Small molecule | — CHEMBL1411 ↗ |
| Route | Intravenous | “administered via continuous i.v. infusion” NCT00896077 ↗ |